CoChat

Thiazolidinedione Therapy Is Not Associated With Increased Colonic Neoplasia Risk in Patients With Diabetes Mellitus

Open access
Lewis, James D., Capra, Angela M., Achacoso, Ninah S., Ferrara, Assiamira, Levin, Theodore R., Quesenberry, Charles P., Habel, Laurel A. · 2008 · Gastroenterology
Cited by 24

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Background & Aims Diabetes mellitus is associated with an increased risk of colorectal cancer. Thiazolidinediones, which are ligands for PPARγ, are widely used to treat patients with diabetes. PPARγ is highly expressed in the colon and exposure to thiazolidinediones has been proposed to affect the risk for colorectal neoplasia. Studies using in vitro models suggest that thiazolidinediones have anti-neoplastic effects, whereas in vivo studies have produced mixed results--some indicate an increased risk for intestinal tumors. This study examined the association between PPARγ-targeted therapies and the risk of colonic neoplasia in patients with diabetes. Methods We conducted 3 retrospective case-control studies nested within the cohort of diabetic patients that were cared for within the Kaiser Permanente of Northern California system from 1994 to 2005. Case subjects were those with colonic neoplasia identified at the time of colonoscopy (study-1), sigmoidoscopy (study-2), or at follow-up lower endoscopy (study-3). Controls had no neoplasia identified at the endoscopic exam. A minimum of 1 year of therapy was used to define medication exposure. Results 14,086 patients were included. Among patients undergoing colonoscopy, there was an inverse association between thiazolidinedione exposure and prevalence of neoplasia (adjusted OR=0.73, 95% CI 0.57–0.92); however, this was not evident among patients without anemia (adjusted OR= 0.97, 95% CI 0.64–1.49). Significant associations between any or long-term thiazolidinedione use and colonic neoplasia were not observed among patients undergoing sigmoidoscopy or serial lower endoscopies. Conclusions These results indicate that thiazolidinedione therapy is not associated with an increased risk for colonic neoplasia.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1053/j.gastro.2008.09.004

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 24

Metadata

Authors
Lewis, J. D., Capra, A. M., Achacoso, N. S., Ferrara, A., Levin, T. R., Quesenberry, C. P., & Habel, L. A.
Venue
Gastroenterology
Publisher
Elsevier BV
Published
2008-12
Volume
135
Issue
6
Pages
1914-1923.e1
ISSN
0016-5085 (ISSN-L)
OpenAlex
W2073868367
Cited by
24
References
5
FWCI
1.12
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Thiazolidinedione Therapy Is Not Associated With Increased Colonic Neoplasia Risk in Patients With Diabetes Mellitus. https://app.cochat.ai/papers/10.1053/j.gastro.2008.09.004
The paper
Lewis, J. D., Capra, A. M., Achacoso, N. S., Ferrara, A., Levin, T. R., Quesenberry, C. P., & Habel, L. A. (2008). Thiazolidinedione Therapy Is Not Associated With Increased Colonic Neoplasia Risk in Patients With Diabetes Mellitus. Gastroenterology. https://doi.org/10.1053/j.gastro.2008.09.004

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.